New York, July 18, 2018: The Drug Delivery Technology Market is expected to exceed more than US$ 1600 Billion by 2021; Growing at a CAGR of 7.5% in the given forecast period.
The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery, transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery and implantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations.
Drug delivery systems are engineered technologies for the targeted shipping and managed launch of healing dealers. Drug delivery is the strategy or procedure of administering a pharmaceutical compound to accomplish a remedial impact in people or animals. For the treatment of human infections, nasal and aspiratory courses of medication conveyance are increasing expanding significance. These courses give promising other options to parenteral medication conveyance especially for peptide and protein therapeutics. For this reason, a few medication conveyance frameworks have been detailed and are being examined for nasal and aspiratory conveyance. These incorporate cyclodextrins, prodrugs, gels, microspheres, proliposomes and liposomes.
You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/drug-delivery-technology-market
The major driving factors of drug delivery technology market are as follows:
Technological advancements and drug innovation
Launching of the new products
Increase in the biologics market
Expanding prevalence of chronic disease
The drug delivery technology market is segmented on the lines of its nasal drug delivery like nasal gels, nasal powder, nasal spray and nasal drops. Under implantable drug delivery segmentation it covers passive implantable drug delivery and active implantable drug delivery. Based on end user segmentation it covers diagnostic centers, home care settings, ASCs/ clinics, hospitals and other end users. The drug delivery technology market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for drug delivery technology and related technologies.
2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.
3) Identifications of new market opportunities and targeted promotional plans for drug delivery technology.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The scope of the report includes a detailed study of global and regional markets for Drug Delivery Technology with the reasons given for variations in the growth of the industry in certain regions.
The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche (Switzerland),Pfizer, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany). Company profile includes details such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Drug delivery technology Market has been segmented as below:
The Drug delivery technology Market is Segmented on the lines of Route of Administration Analysis, End-user Analysis and Regional Analysis. By Route of Administration Analysis this market is segmented on the basis of Pulmonary drug delivery, Ocular drug delivery, Topical drug delivery, Transmucosal drug delivery, Oral drug delivery, Injectable drug delivery, Nasal drug delivery and Implantable drug delivery. Pulmonary drug delivery its covers Nebulizers, Dry powder inhaler and Metered dose inhaler. Ocular drug delivery its covers Ocular devices, Semi solid and Liquid. Topical drug delivery its covers Transdermal, Solid, Semi solid and Liquid. Transmucosal drug delivery its covers Oral and Other. Oral drug delivery its covers Liquid, Solid and Semi solid. Injectable drug delivery its covers Devices and Formulations. Nasal drug delivery its covers Nasal gels, Nasal powder, Nasal spray and Nasal drops. Implantable drug delivery its covers Passive implantable drug delivery and Active implantable drug delivery.
By End-user Analysis this market is segmented on the basis of Diagnostic centers sector, Home care settings sector, ASCs/ Clinics sector, Hospitals sector and Other end users sectors. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Drug Delivery Technology Market, By Route of Administration
8 Drug Delivery Technology Market, By Facility of Use
9 Drug Delivery Technology Market, By Region
10 Competitive Landscape
11 Company Profiles
11.2 Johnson & Johnson Services, Inc.
11.3 Novartis AG
11.4 F. Hoffmann-La Roche Ltd.
11.5 Pfizer, Inc.
11.6 Bayer AG
11.7 Antares Pharma, Inc.
11.8 Becton, Dickinson and Company
11.9 Glaxosmithkline PLC
11.11 Merck & Co., Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States